Search details
1.
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Gynecol Oncol
; 164(1): 18-26, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34696892
2.
A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy.
Oncologist
; 26(10): e1870-e1879, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34216177
3.
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
Breast Cancer
; 30(2): 315-328, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36602669
4.
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study.
Breast
; 54: 256-263, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-33188992
5.
Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial.
JAMA Oncol
; 6(12): 1923-1930, 2020 Dec 01.
Article
in English
| MEDLINE | ID: mdl-33030515
6.
A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas.
Radiother Oncol
; 125(1): 160-167, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28951009
7.
[Anticancer drugs management in renal insufficiency patients]. / Gestion des agents anticancéreux chez les insuffisants rénaux.
Bull Cancer
; 99(3): 323-31, 2012 Mar 01.
Article
in French
| MEDLINE | ID: mdl-22123599
Results
1 -
7
de 7
1
Next >
>>